Trials / Completed
CompletedNCT02212951
Comparison of Postprandial Glucose Control Associated With BIOD-531 vs. Humalog Mix 75/25 vs. Humulin R U-500
A Single-blind Crossover Study of the Pharmacokinetic and Postprandial Glucose Dynamics of BIOD-531 Compared to Humulin R U-500 and Humalog Mix 75/25 in Subjects With Type 2 Diabetes Mellitus Who Are Treated With 50-200 Units of Insulin Per Day
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Biodel · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The study is to compare meal time glucose control associated with BIOD-531, a rapidly absorbed concentrated insulin to that associated with Humalog Mix 75/25 and Humulin R U-500.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BIOD-531 | |
| DRUG | Humalog Mix 75/25 | |
| DRUG | Humulin R U-500 |
Timeline
- Start date
- 2014-05-01
- Primary completion
- 2014-07-01
- First posted
- 2014-08-11
- Last updated
- 2016-02-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02212951. Inclusion in this directory is not an endorsement.